Cytokinetics initiated with outperform rating by William Blair
CYTK•William Blair initiated coverage of Cytokinetics with an outperform rating.
Related News
UK stocks set for weekly gains as investors seek shelter in defensive sectors
EWU•
Borr Drilling director Tor Olav Troim reports $2.3 million share acquisition
BORR•
BMO cuts Netflix target price to $125 from $135
NFLX•
Eli Lilly's weight-loss pill wins EU drug regulator's backing
LLY•
Enerflex Ltd.: BMO raises target price to C$50 from C$48
EFX•